Literature DB >> 10469693

The influence of donated gametes on the incidence of hypertensive disorders of pregnancy.

O Salha1, V Sharma, T Dada, D Nugent, A J Rutherford, A J Tomlinson, S Philips, V Allgar, J J Walker.   

Abstract

Pregnancies achieved from oocyte, sperm or embryo donation are unique, since they have resulted from donor gametes that are immunologically foreign to the mother. Thus, studying the obstetric outcome of such pregnancies may shed some light on the pathophysiology of preeclampsia, particularly in women conceiving with donated embryos, since the entire fetal genome is allogenic in these pregnancies. In this retrospective cohort study, a total of 144 women were studied. Of these, 72 were infertility patients who had conceived as a result of sperm, ovum or embryo donation and the other 72 women were age- and parity-matched control patients who became pregnant with their own gametes, either spontaneously, or following intrauterine insemination with their partner's spermatozoa. Study patients were divided into three groups depending on the origin of the donated gametes. Group 1 consisted of pregnancies achieved by intrauterine insemination with washed donor spermatozoa (n = 33). Group 2 included women who conceived using donated oocytes (n = 27) and group 3 consisted of women who conceived as a result of embryo donation (n = 12). The incidence of pregnancy-induced hypertension in the donated gametes study group was 12.5% (9/72) compared with 2.8% (2/72) in the control group. In addition, pre-eclampsia was diagnosed in 18.1% (13/72) of the donated gametes study group compared to 1.4% (1/72) in the age- and parity-matched controls. The increased incidence of gestational hypertension in pregnancies resulting from donated gametes gives evidence for a maternal genetic component, with an equally strong fetal influence, in the complicated aetiology of gestational hypertension, and pre-eclampsia in particular.

Entities:  

Mesh:

Year:  1999        PMID: 10469693     DOI: 10.1093/humrep/14.9.2268

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  33 in total

1.  Maternal-fetal HLA sharing and preeclampsia: variation in effects by seminal fluid exposure in a case-control study of nulliparous women in Iowa.

Authors:  Elizabeth W Triche; Karisa K Harland; Elizabeth H Field; Linda M Rubenstein; Audrey F Saftlas
Journal:  J Reprod Immunol       Date:  2013-08-06       Impact factor: 4.054

2.  Hypertensive disorders of pregnancy and infertility treatment: a population-based survey among United States women.

Authors:  Brent C Monseur; Jerrine R Morris; Heather S Hipp; Vincenzo Berghella
Journal:  J Assist Reprod Genet       Date:  2019-05-27       Impact factor: 3.412

3.  Seminal fluid drives expansion of the CD4+CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice.

Authors:  Sarah A Robertson; Leigh R Guerin; John J Bromfield; Kim M Branson; Aisling C Ahlström; Alison S Care
Journal:  Biol Reprod       Date:  2009-01-21       Impact factor: 4.285

4.  Oocyte donation: a risk factor for pregnancy-induced hypertension: a meta-analysis and case series.

Authors:  Ulrich Pecks; Nicolai Maass; Joseph Neulen
Journal:  Dtsch Arztebl Int       Date:  2011-01-21       Impact factor: 5.594

5.  Is ethnicity a risk factor for developing preeclampsia? An analysis of the prevalence of preeclampsia in China.

Authors:  J Xiao; F Shen; Q Xue; G Chen; K Zeng; P Stone; M Zhao; Q Chen
Journal:  J Hum Hypertens       Date:  2014-01-16       Impact factor: 3.012

6.  The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.

Authors:  Liona C Poon; Andrew Shennan; Jonathan A Hyett; Anil Kapur; Eran Hadar; Hema Divakar; Fionnuala McAuliffe; Fabricio da Silva Costa; Peter von Dadelszen; Harold David McIntyre; Anne B Kihara; Gian Carlo Di Renzo; Roberto Romero; Mary D'Alton; Vincenzo Berghella; Kypros H Nicolaides; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2019-05       Impact factor: 3.561

Review 7.  A new era in reproductive medicine: consequences of third-party oocyte donation for maternal and fetal health.

Authors:  Shigeru Saito; Yasushi Nakabayashi; Akitoshi Nakashima; Tomoko Shima; Osamu Yoshino
Journal:  Semin Immunopathol       Date:  2016-06-20       Impact factor: 9.623

Review 8.  From victim to survivor to thriver: helping women with primary ovarian insufficiency integrate recovery, self-management, and wellness.

Authors:  Evelina Weidman Sterling; Lawrence M Nelson
Journal:  Semin Reprod Med       Date:  2011-10-03       Impact factor: 1.303

9.  Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia.

Authors:  Y Sasaki; D Darmochwal-Kolarz; D Suzuki; M Sakai; M Ito; T Shima; A Shiozaki; J Rolinski; S Saito
Journal:  Clin Exp Immunol       Date:  2007-04-25       Impact factor: 4.330

Review 10.  Pathophysiology of placentation abnormalities in pregnancy-induced hypertension.

Authors:  Mitsuko Furuya; Junji Ishida; Ichiro Aoki; Akiyoshi Fukamizu
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.